Effect of Grape seed extract in blood parameters associated with Experimental Thyroid Disorders in White Male Rats
Jameel K. Alumeri, Ahmed Jassem AL-Naely
Department of Biology, College of Education, University of Al-Qadisyiah, Iraq.
*Corresponding Author E-mail: Jameel.wali@qu.edu.iq
ABSTRACT:
To evaluate the role of grape seed extract in mitigation the effects of thyroid disorders on some blood parameters, Sixty healthy male white rats were used in the current study, divided in six groups (n=10) each group treated as flow: control group (C) given distil water for 45 days. First treatment (T1) given oral dose of 30 mg/kg carbimazole for 45 days as control positive, Second treatment (T2) given oral dose of 20mg/kg L-thyroxin for 45 days as control positive, Third treatment (T3) given oral dose of 150mg/kg GSE for 45 days as control negative, Fourth treatment (T4) given oral dose of 30mg/kg carbimazole for 15 days to induced hypothyroidism then given 30mg/kg carbimazole synchronously with 150mg/kg GSE for 30 days. Fifth treatment (T5) given oral dose of 20mg/kg L-thyroxin for 15 days to induced hyperthyroidism then given 20mg/kg L-thyroxin synchronously with 150mg/kg GSE for 30 days. The results (table1) showed that there was no significant decrease (P>0.05) in RBC result in T1 but was there significant increase (P<0.05) in T2 treatment compared with control, while results showed significant decrease (P<0.05) in each of PCV, Hb and ESR in booth T1 and T2 treatments compared with control, Total count of WBC results (table 2) showed significant increase (P<0.05) in T1 and significant decrease (P<0.05) in T2 compared with control, This was accompanied by significant differences in MO, ECIDO, LY and NE when comparing the results of these parameters in T1 and T2 treatments with control. As for T3 treatment which in turn were closely related without no significant difference with control group. Fourth group results experienced improvement in RBCs and Hb closely to control whereas PCV parameter was relative to control and also not significantly different from its rate in the first group, ESR results in this group did not differ significantly compared with control group while WBC results decreased significantly (P<0.05) compared with control and T1. The fifth group result they were close to normal range of all parameters in control group as well as compared with third treatment, in contrast results of this fifth treatment were differ significantly towards improvement in these parameters compared with second group which treated with L-thyroxin alone. According to these results we can conclude that grape seeds extract have important role in mitigation thyroid disorders on blood parameters.
KEYWORDS: Grape seeds extract, hypothyroidism, hyperthyroidism, thyroid.
INTRODUCTION:
The relationship between thyroid hormone disorders and blood parameters has been known from ancient times, In 1979 the researcher Fein mentioned that Graves' disease association with anemia as well as2 noted there is decrease in red blood cells after thyroidectomy in peripheral blood, on the other hand hypothyroidism can cause form of anemia usually is macrocytic hypochromic anemia in moderate severity while hyperthyroidism commonly cause erythrocytosis3. hypothyroidism and hypothyroidism cause a state of oxidative stress and this in turn affects the nature of plasma lipid4,5. In general many studies have found that blood parameters are normal if euthyroid stat is achieved6.
Carbimazole is anti-hyperthyroidism drug by reducing the intake of iodine and formation of diodotyrosine which prevents coupling of thyroid peroxidase enzyme and iodination of tyrosine residues on thyroglobulin and reduce production of thyroid hormones lead hypothyroidism7, L-thyroxin is anti-hypothyroidism drug can be used to induced hyperthyroidism in rodents8.
Grape seed extract (GSE) is a nutritional supplement with important health benefits9, Because it is a complex mixture of polyphenols consist of flavonoids and nonflavonoids compounds10. This plant extract has many benefits include cardioprotective benefits11, Renoprotective12 as well as neuroprotective13. The grape seed extract GSE known for its ability to treat anemia and has various biological functions due to it rich polyphenol ingredients14, Therefore, it was used in this study to verify its role in reducing the effects of thyroid disorders on some blood parameters.
MATERIAL AND METHODS:
Sixty healthy male rats 210-250g weight and 10-12 weeks age were used in the current study, divided in six groups (n=10) each group Treated as flow: control group (C) given distil water for 45 days. First treatment (T1) given oral dose of 30mg/kg carbimazole for 45 days as control positive, Second treatment (T2) given oral dose of 20mg/kg L-thyroxin for 45 days as control positive, Third treatment (T3) given oral dose of 150mg/kg GSE for 45 days as control negative, Fourth treatment (T4) given oral dose of 30mg/kg carbimazole for 15 days to induced hypothyroidism then given 30mg/kg carbimazole synchronously with 150mg/kg GSE for 30 days. Fifth treatment (T5) given oral dose of 20mg/kg L-thyroxin for 15 days to induced hyperthyroidism then given 20mg/kg L-thyroxin synchronously with 150 mg/kg GSE for 30 days.
Plant extract: Local Iraqi Grape was purchased from local Iraqi markets, Seeds were isolated and drying it in the shade, then grind by an electric mixer for use in the Soxhlet apparatus for water extract of grape seeds.
Animals scarified: In 46 day animals were sacrificed blood samples were collected by directly heart puncture for blood parameters assays by hematology analyzer apparatus model.
Statistical Analysis
All results of the study were subjected for statistical analysis in order to know the significant differences between the groups by using F-test at 0.05 probability level15.
RESULTS:
The results (table1) showed that there was no significant decrease (P>0.05) in RBC result in T1 but was there significant increase (P<0.05) in T2 treatment compared with control, while results showed significant decrease (P<0.05) in each of PCV, Hb and ESR in booth T1 and T2 treatments compared with control, Total count of WBC results(table 2) showed significant increase (P<0.05) in T1 and significant decrease (P<0.05) in T2 compared with control, This was accompanied by significant differences in MO, ECIDO, LY and NE when comparing the results of these parameters in T1 and T2 treatments with control.
As for T3 treatment which in turn were closely related without no significant difference with control group.
Fourth group results experienced improvement in RBCs and Hb closely to control whereas PCV parameter was relative to control and also not significantly different from its rate in the first group, ESR results in this group did not differ significantly compared with control group while WBC results decreased significantly (P<0.05) compared with control and T1. The fifth group result they were close to normal range of all parameters in control group as well as compared with third treatment, in contrast results of this fifth treatment were differ significantly towards improvement in these parameters compared with second group which treated with L-thyroxin alone.
Table (1): Grape seeds extract effects in some blood parameters in white male rat.
Parameters
Treatments |
RBCs (x1012/L)
|
PCV % |
Hb g/dl |
ESR |
Control |
7.45±0.13 b |
45.82±2.12 a |
13.65±0.66 a |
4.49±0.33 a |
T1
|
7.54±0.39 b |
40.36±3.17 c |
11.70±1.03 c |
3.33±0.33 b |
T2
|
8.23±0.26 a |
43.33±1.73 b |
10.96±0.52 b |
3.00±0.57 b |
T3 |
7.39±0.11 b |
45.43±0.22 a |
13.77±0.54 a |
4.79±0.23 a |
T4 |
7.76±0.45 b |
41.40±1.53 ac |
12.56±0.43 a |
4.33±0.11 a |
T5 |
8.01±0.20 ab |
44.96±0.75 a |
13.53±0.26 a |
4.00±0.02 a |
Means ± SE
Table (2): Grape seeds extract effects in total and deferential WBC count.
Parameters Treatments |
WBCs (x109/L) |
NE % |
LY % |
MO % |
ECIDO % |
Control |
12.195±0.37 b |
27.13±0.33 a |
69.58±0.09 c |
2.29±0.33 a |
1.00±0.001 a |
T1
|
15.51±2.46 a |
29.43±4.83 a |
69.40±5.57 c |
0.80±0.56 b |
0.37±0.006 b |
T2 |
6.35±2.93 c |
14.26±3.45 b |
85.53±9.45 a |
0.1667±0.33 a |
0.0667±0.006 c |
T3 |
13.14±0.55 b |
29.39±0.52 a |
67.61±2.22 c |
2.00±0.57 a |
1.00± 0.001 a |
T4 |
12.99±2.33 b |
25.71±5.03 a |
72.76±6.11 b |
1.20±0.001 b |
0.333±0.001 b |
T5 |
7.91±0.44 c |
25.46±4.02 a |
72.40±4.18 b |
0.400±0.30 a |
0.0333±0.003 d |
Means ± SE
DISCUSSION:
Thyroid hormones regulates body metabolism so any functional or histological disorder in thyroid gland maybe effects functions of cells and organs of the body this includes bone marrow which affected by thyroid disorders this causes oxidative stress especially in hypothyroidism leading to anemia16,17, In our result there was no significant decrease in RBCs count in carbimazole compared with control treatment but we noticed differ form of anemia represent by significant decrease in Hb and PCV compared with control that maybe refer to microcytic hypochromic anemia, Many studies pointed out that hypothyroidism cause various forms of anemia like microcytic hypochromic anemia this generally attributed to malabsorption of iron18 Because of most of previous studies have confirmed a relationship between hypothyroidism and iron deficiency 19.
Microcytic hypochromic anemia means small size and low weight of erythrocytes due to lack of quantity of hemoglobin this can cause delay red blood cells to fall into the test tube and thus maybe the reason for decrease the erythrocyte sedimentation rate as we not in carbimazole treatment. Significant increase in RBC count in L-thyroxin treatment may be due to increase the production of red blood cells from the bone marrow, because of in hyperthyroidism erythrocytosis is common 3 by two way either increase secretion of erythropoietin from kidney which is stimulates erythrocytes production from bone marrow7,8 , or by increase basal metabolic rate through thyroid hormones which accelerate RBC formation20, This rapid production process consider as a kind of stress on bone marrow may lead to Produce small erythrocyte with low hemoglobin concentration as the results of Hb and PCV showed in L-thyroxin treatment compared with control, Where hyperthyroidism interferes with iron metabolism the influence of thyroid hormones on the synthesis/ regulation of hepcidin an important regulator of iron metabolism 21, Increased red blood cells may be behind a decrease in ESR in this group. Also this great production of red blood cells in bone marrow may have significantly reduced the production of WBC in this treatment as our results showed. This corresponds to a study of 22, who concluded that treatment of rats with L-thyroxin for28 days decrease WBC count, Because of hyperthyroidism cause depressed in total leucocytes with relative decrease in neutrophil3.
In addition thyroid disorders are usually accompanied with malnutrition and an unhealthy decreases in body weight23,24, this case is most severe in hypothyroidism who developed by carbimazole drug may be because its’ bad taste and its effect on the digestive system leads to malnutrition25,26, in T1 treatment observed decrease in food and water consumption, There for the decrease in ESR in T1and T2 may be due to some chemical and physical changes in the properties of plasma in some cases, Like malnutrition and oxidative stress caused by thyroid disorders4,5 that mean changes in nature, quantity, density and viscosity of plasma, in particular increased plasma density due to drought or oxidative stress all this leads to increased density of plasma, which in turn causes lower because of the difficulty of deposition of blood cells into the test tube.
Many studies confirmed that thyroid disorders cause damage to the body organs27,28. By inflammation and oxidative stress for example carbimazole induced Cholestatic Hepatitis and serositis29, and the Hepatitis is associated with elevated WBC30, that maybe explained the significant increase of WBC in carbimazole treatment specially in neutrophils as the first line of defense against the body against inflammations.
Conversely T4 and T5 treatments in which administrated GSE Synchronized with both drugs giving showed significant improvement in RBC, PCV, HB, ESR WBC, NE, LY compared with T1 and T2, GSE can contribute to this improvement first by antioxidant ability of grape seeds extract through some of its compounds like Phenolic, Flavonoids and Non-flavonoids which are known for their high ability to control free radicals 31-33, this protect cells and tissues from the risk of organs damage like kidney protection caused by free radicals which occurs due to thyroid disorders and its drugs34,35, And thus can perform its functions efficiently like erythropoietin production, As Flavonoids play an important roles in the defense against biotic and abiotic stresses36.
Also GSE rich with Procyanidins which performed very well as anti-inflammatory, that maybe explained WBC count decrease in T4 (Carbimazole + GSE treatment).
The second way is grape extract contains proteins, amino acids, Glycosides, vitamins, Lipids, Carbohydrates, Organic acids, Phenolic acids and minerals 37,38, this makes GSE has high nutritional value, thus addressing malnutrition caused by thyroid disorders, it Supports the cells with necessary materials to make the proteins and building tissues, thus contributing to the formation of blood elements and improving the plasma state.
ACKNOWLEDGEMENT:
The author is grateful to the Deanship of education and Veterinary and the Department of biology / Al-Qadisyiah University to provide all facilities for the success of this work
CONFLICT OF INTEREST:
The authors declare no conflict of interest.
REFERENCES:
1. J.M. Stephen, A.P. Maxine, Endocrine disorders. In: Paul A. Fitzgerald, eds. Current Medical Diagnosis and Treatment., New York, 2012.
2. L. Horton, R. Coburn, J. England, R. Himsworth, The haematology of hypothyroidism, QJM: An International Journal of Medicine.1976, 45(1) 101-123.
3. M. Iddah, B. Macharia, A. Ng’wena, A. Keter, A. Ofulla, Thryroid hormones and hematological indices levels in thyroid disorders patients at Moi teaching and referral hospital, Western Kenya, ISRN endocrinology 2013.
4. P. Venditti, M. Balestrieri, S. Di Meo, T. De Leo, Effect of thyroid state on lipid peroxidation, antioxidant defences, and susceptibility to oxidative stress in rat tissues, Journal of Endocrinology.1997, 155(1),151-157.
5. G. Bianchi, E. Solaroli, V.A.A. Zaccheroni, G. Grossi, A. Bargossi, N. Melchionda, G. Marchesini, Oxidative Stress and Anti-Oxidant Metabolites in Patients with Hyperthyroidism: Effect of Treatment, Hormone and metabolic research.1999, 31(11), 620-624.
6. T.H. Banday, S.B. Bhat, S.B. Bhat, N. Shah, S. Bashir, To study prevalence of incipient iron deficiency in primary hypothyroidism, International Journal of Research in Medical Sciences.2017, 2(2),472-475.
7. M. Sharma, A. KOTY, A.J. AL RAJAB, A simple and effective method for determination of the antithyroid drug carbimazole using ruthenium trichloride, Turkish Journal of Chemistry.2017, 41(6), 995-1012.
8. A.C. Bianco, G. Anderson, D. Forrest, V.A. Galton, B. Gereben, B.W. Kim, P.A. Kopp, X.H. Liao, M.J. Obregon, R.P. Peeters, American Thyroid Association Guide to Investigating Thyroid Hormone Economy and Action in Rodent and Cell Models: Report of the American Thyroid Association Task Force on Approaches and Strategies to Investigate Thyroid Hormone Economy and Action, Thyroid.2014, 24(1),88-168.
9. W. Suwannaphet, A. Meeprom, S. Yibchok-Anun, S. Adisakwattana, Preventive effect of grape seed extract against high-fructose diet-induced insulin resistance and oxidative stress in rats, Food and Chemical Toxicology.2010, 48(7),1853-1857.
10. R. Khanal, L. Howard, R. Prior, Procyanidin content of grape seed and pomace, and total anthocyanin content of grape pomace as affected by extrusion processing, Journal of Food Science.2009,74(6),H174-H182.
11. K. Décordé, P.L. Teissèdre, T. Sutra, E. Ventura, J.P. Cristol, J.M. Rouanet, Chardonnay grape seed procyanidin extract supplementation prevents high‐fat diet‐induced obesity in hamsters by improving adipokine imbalance and oxidative stress markers, Molecular nutrition and food research.2009, 53(5),659-666.
12. J. Safa, H. Argani, B. Bastani, N. Nezami, B.R. Ardebili, A. Ghorbanihaghjo, H. Kalagheichi, A. Amirfirouzi, M. Mesgari, J.S. Rad, Protective effect of grape seed extract on gentamicin-induced acute kidney injury, Iranian Journal of Kidney Diseases.2010, 4(4) ,285.
13. Y.-J. Wang, P. Thomas, J.-H. Zhong, F.-F. Bi, S. Kosaraju, A. Pollard, M. Fenech, X.-F. Zhou, Consumption of grape seed extract prevents amyloid-β deposition and attenuates inflammation in brain of an Alzheimer’s disease mouse, Neurotoxicity research.2009, 15(1),3-14.
14. J. Shi, J. Yu, J.E. Pohorly, Y. Kakuda, Polyphenolics in grape seeds—biochemistry and functionality, Journal of medicinal food.2003, 6(4),291-299.
15. K. Al-Rawi, A. Khalaf Allah, Design and Analysis of Experiments., National Library for Publication, University of Mosul, Ministry of Higher Education and Scientific Research, Iraq, 2000.
16. A.R. Axelrod, L. Berman, The bone marrow in hyperthyroidism and hypothyroidism, Blood, J. Hematol.1951, 6, 436-453.
17. M.P. Kawa, K. Grymuła, E. Paczkowska, M. Baśkiewicz-Masiuk, E. Dąbkowska, M. Koziołek, M. Tarnowski, P. Kłos, V. Dziedziejko, M. Kucia, Clinical relevance of thyroid dysfunction in human haematopoiesis: biochemical and molecular studies, European journal of endocrinology.2010, 162(2),295-305.
18. A. Dorgalaleh, M. Mahmoodi, B. Varmaghani, Effect of thyroid dysfunctions on blood cell count and red blood cell indice, Iranian journal of pediatric hematology and oncology.2013, 3(2),73.
19. C.S. Lima, D.E.Z. Wittmann, V. Castro, M.A. Tambascia, I. Lorand-Metze, S.T. Saad, F.F. Costa, Pancytopenia in untreated patients with Graves' disease, Thyroid.2006 16(4)403-409.
20. A. Guyton, J. Hall, Thyroid Metabolic Hormones. 931-943. In: Guyton and Hall Textbook of Medical Physiology, Elsevier, United States of America,2011.
21. S. Fischli, V. von Wyl, M. Trummler, D. Konrad, S. Wueest, A. Ruefer, K. Heering, R. Streuli, C. Steuer, L. Bernasconi, Iron metabolism in patients with Graves’ hyperthyroidism, Clinical endocrinology.2017, 87(5),609-616.
22. I. Osonuga, M. Olowookorun, I. Iquot, B. Akinola, Influence of Thyroxine on Blood Parameters and Liver Enzymes in Adult Male and Female Rats, African Journal of Biomedical Research.2014, 17(1),53-56.
23. M. Messarah, A. Boumendjel, A. Chouabia, F. Klibet, C. Abdennour, M.S. Boulakoud, A. El Feki, Influence of thyroid dysfunction on liver lipid peroxidation and antioxidant status in experimental rats, Experimental and Toxicologic Pathology.2010, 62(3),301-310.
24. R. MOORE, I.H. MILLS, Serum T3 and T4 levels in patients with anorexia nervosa showing transient hyperthyroidism during weight gain, Clinical endocrinology.1979, 10(5) 443-449.
25. D.S. Cooper, Antithyroid drugs, New England Journal of Medicine.2005,352(9) ,905-917.
26. R. Daher, T. Yazbeck, J.B. Jaoude, B. Abboud, Consequences of dysthyroidism on the digestive tract and viscera, World journal of gastroenterology: WJG.2009, 15(23) ,2834.
27. G. Basu, A. Mohapatra, Interactions between thyroid disorders and kidney disease, Indian journal of endocrinology and metabolism.2012, 16(2),204.
28. T.M. Khan, S. Malik, I.U. Diju, Correlation between plasma thyroid hormones and liver enzymes level in thyrotoxic cases and controls in Hazara Division, Journal of Ayub Medical College Abbottabad.2010, 22(2),176-179.
29. R. Amith, H. Madhukara, Carbimazole-induced Cholestatic Hepatitis in Toxic Multinodular Goiter, International Journal of Scientific Study.2016, 4(5),251-253.
30. T. Hardy, C. Wells, S. Kendrick, M. Hudson, C.P. Day, A.D. Burt, S. Masson, S.F. Stewart, White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers, BMC gastroenterology.2013, 13(1),55.
31. A. Crozier, M.N. Clifford, H. Ashihara, Plant secondary metabolites: occurrence, structure and role in the human diet, John Wiley and Sons2008.
32. A. Hernandez-Jimenez, E. Gomez-Plaza, A. Martinez-Cutillas, J.A. Kennedy, Grape skin and seed proanthocyanidins from Monastrell× Syrah grapes, Journal of agricultural and food chemistry.2009, 57(22),10798-10803.
33. E. Pastrana-Bonilla, C.C. Akoh, S. Sellappan, G. Krewer, Phenolic content and antioxidant capacity of muscadine grapes, Journal of agricultural and food chemistry.2003, 51(18),5497-5503.
34. L. Bao, Z. Zhang, X. Dai, Y. Ding, Y. Jiang, Y. Li, Y. Li, Effects of grape seed proanthocyanidin extract on renal injury in type 2 diabetic rats, Molecular medicine reports.2015, 11(1), 645-652.
35. I.M. El‐Ashmawy, A.E. Bayad, Folic Acid and Grape Seed Extract Prevent Azathioprine‐induced Fetal Malformations and Renal Toxicity in Rats, Phytotherapy research.2016, 30(12),2027-2035.
36. L. Pourcel, J.-M. Routaboul, V. Cheynier, L. Lepiniec, I. Debeaujon, Flavonoid oxidation in plants: from biochemical properties to physiological functions, Trends in plant science.2007, 12(1),29-36.
37. J. Yamakoshi, M. Saito, S. Kataoka, M. Kikuchi, Safety evaluation of proanthocyanidin-rich extract from grape seeds, Food and Chemical Toxicology.2002, 40(5),599-607.
38. J.G. Nirmala, R. Narendhirakannan, In vitro antioxidant and antimicrobial activities of grapes (Vitis vinifera L) seed and skin extracts–Muscat variety, Int J Pharm Pharm Sci.2011, 3(4),242-249.
Received on 04.05.2019 Modified on 11.06.2019
Accepted on 01.07.2019 © RJPT All right reserved
Research J. Pharm. and Tech. 2019; 12(12): 5711-5715.
DOI: 10.5958/0974-360X.2019.00988.0